BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ;  PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing vs shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. 2004;110:2591-2596. [PMID: 15492306 DOI: 10.1161/01.cir.0000145610.64014.e4] [Cited by in Crossref: 564] [Cited by in F6Publishing: 79] [Article Influence: 33.2] [Reference Citation Analysis]
Number Citing Articles
1 Sapp JL, Parkash R, Wells GA, Yetisir E, Gardner MJ, Healey JS, Thibault B, Sterns LD, Birnie D, Nery PB, Sivakumaran S, Essebag V, Dorian P, Tang AS. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial. Circ: Arrhythmia and Electrophysiology 2017;10. [DOI: 10.1161/circep.116.004875] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
2 Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220. [PMID: 22179539 DOI: 10.1161/cir.0b013e31823ac046] [Cited by in Crossref: 2492] [Cited by in F6Publishing: 1551] [Article Influence: 249.2] [Reference Citation Analysis]
3 Borne RT, Katz D, Betz J, Peterson PN, Masoudi FA. Implantable Cardioverter-Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review. J Am Heart Assoc 2017;6:e005515. [PMID: 28258050 DOI: 10.1161/JAHA.117.005515] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
4 Hussaini S, Venkatesan V, Biasci V, Romero Sepúlveda JM, Quiñonez Uribe RA, Sacconi L, Bub G, Richter C, Krinski V, Parlitz U, Majumder R, Luther S. Drift and termination of spiral waves in optogenetically modified cardiac tissue at sub-threshold illumination. Elife 2021;10:e59954. [PMID: 33502313 DOI: 10.7554/eLife.59954] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Tripathy RK, Zamora-Mendez A, de la O Serna JA, Paternina MRA, Arrieta JG, Naik GR. Detection of Life Threatening Ventricular Arrhythmia Using Digital Taylor Fourier Transform. Front Physiol 2018;9:722. [PMID: 29951004 DOI: 10.3389/fphys.2018.00722] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 6.7] [Reference Citation Analysis]
6 Ruwald AC, Schuger C, Moss AJ, Kutyifa V, Olshansky B, Greenberg H, Cannom DS, Estes NA, Ruwald MH, Huang DT, Klein H, McNitt S, Beck CA, Goldstein R, Brown MW, Kautzner J, Shoda M, Wilber D, Zareba W, Daubert JP. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Circ Arrhythm Electrophysiol 2014;7:785-92. [PMID: 25136077 DOI: 10.1161/CIRCEP.114.001623] [Cited by in Crossref: 88] [Cited by in F6Publishing: 13] [Article Influence: 12.6] [Reference Citation Analysis]
7 Lewandowski M, Przybylski A, Kuźmicz W, Szwed H. Reduction of the inappropriate ICD therapies by implementing a new fuzzy logic-based diagnostic algorithm. Ann Noninvasive Electrocardiol 2013;18:457-66. [PMID: 24047490 DOI: 10.1111/anec.12090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Stevenson WG, Chaitman BR, Ellenbogen KA, Epstein AE, Gross WL, Hayes DL, Strickberger SA, Sweeney MO. Clinical Assessment and Management of Patients With Implanted Cardioverter-Defibrillators Presenting to Nonelectrophysiologists. Circulation 2004;110:3866-9. [DOI: 10.1161/01.cir.0000149716.03295.7c] [Cited by in Crossref: 47] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
9 Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018;137:e67-e492. [PMID: 29386200 DOI: 10.1161/cir.0000000000000558] [Cited by in Crossref: 3193] [Cited by in F6Publishing: 1299] [Article Influence: 1064.3] [Reference Citation Analysis]
10 Ponamgi SP, DeSimone CV, Ackerman MJ. Athletes with Implantable Cardioverter Defibrillators. Clin Sports Med 2015;34:473-87. [PMID: 26100423 DOI: 10.1016/j.csm.2015.03.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017;135:e146-e603. [PMID: 28122885 DOI: 10.1161/cir.0000000000000485] [Cited by in Crossref: 4860] [Cited by in F6Publishing: 2154] [Article Influence: 1215.0] [Reference Citation Analysis]
12 Trivedi A, Knight BP. ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy. Arrhythm Electrophysiol Rev 2016;5:188-96. [PMID: 28116084 DOI: 10.15420/aer.2016:30:2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
13 Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015;131:e29-322. [PMID: 25520374 DOI: 10.1161/cir.0000000000000152] [Cited by in Crossref: 3351] [Cited by in F6Publishing: 2264] [Article Influence: 478.7] [Reference Citation Analysis]
14 Sun AY, Koontz JI, Shah SH, Piccini JP, Nilsson KR Jr, Craig D, Haynes C, Gregory SG, Hranitzky PM, Pitt GS. The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fraction. Circ Cardiovasc Genet 2011;4:163-8. [PMID: 21498565 DOI: 10.1161/CIRCGENETICS.110.958652] [Cited by in Crossref: 36] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
15 Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017. [PMID: 18768944 DOI: 10.1056/nejmoa071098] [Cited by in Crossref: 1015] [Cited by in F6Publishing: 160] [Article Influence: 78.1] [Reference Citation Analysis]
16 Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 2014;129:e28-e292. [PMID: 24352519 DOI: 10.1161/01.cir.0000441139.02102.80] [Cited by in Crossref: 2899] [Cited by in F6Publishing: 2490] [Article Influence: 362.4] [Reference Citation Analysis]
17 Li W, Ripplinger CM, Lou Q, Efimov IR. Multiple monophasic shocks improve electrotherapy of ventricular tachycardia in a rabbit model of chronic infarction. Heart Rhythm 2009;6:1020-7. [PMID: 19560090 DOI: 10.1016/j.hrthm.2009.03.015] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
18 Yee R, Fisher JD, Birgersdotter-green U, Smith TW, Kenigsberg DN, Canby R, Jackson T, Taepke R, Degroot P. Initial Clinical Experience With a New Automated Antitachycardia Pacing Algorithm: Feasibility and Safety in an Ambulatory Patient Cohort. Circ: Arrhythmia and Electrophysiology 2017;10. [DOI: 10.1161/circep.116.004823] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
19 Sears SF, Shea JB, Conti JB. How to Respond to an Implantable Cardioverter-Defibrillator Shock. Circulation 2005;111. [DOI: 10.1161/circulationaha.104.508663] [Cited by in Crossref: 46] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
20 Chinushi M, Saitoh O, Furushima H, Aizawa Y, Noda T, Nitta T, Ohe T, Kurita T. Anti-tachycardia pacing for non-fast and fast ventricular tachycardias in individual Japanese patients: From Nippon-storm study. J Arrhythm 2021;37:1038-45. [PMID: 34386130 DOI: 10.1002/joa3.12572] [Reference Citation Analysis]
21 Lo R, Al-Ahmad A, Hsia H, Zei PC, Wang PJ. Optimal Programming of ICDs for Prevention of Appropriate and Inappropriate Shocks. Curr Treat Options Cardiovasc Med 2008;10:408-16. [PMID: 18814830 DOI: 10.1007/s11936-008-0032-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Arenal A, Proclemer A, Kloppe A, Lunati M, Martìnez Ferrer JB, Hersi A, Gulaj M, Wijffels MC, Santi E, Manotta L, Mangoni L, Gasparini M. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial. Europace 2016;18:1719-25. [PMID: 27485577 DOI: 10.1093/europace/euw032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
23 Fang Y, Gu K, Yang B, Ju W, Chen H, Li M, Liu H, Wang J, Yang G, Chen M. What factors lead to the acceleration of ventricular tachycardia during antitachycardia pacing?-Results from over 1000 episodes. J Arrhythm 2018;34:36-45. [PMID: 29721112 DOI: 10.1002/joa3.12010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Gulizia MM, Piraino L, Scherillo M, Puntrello C, Vasco C, Scianaro MC, Mascia F, Pensabene O, Giglia S, Chiarandà G, Vaccaro I, Mangiameli S, Corrao D, Santi E, Grammatico A; PITAGORA ICD Study Investigators. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial. Circ Arrhythm Electrophysiol 2009;2:146-53. [PMID: 19808459 DOI: 10.1161/CIRCEP.108.804211] [Cited by in Crossref: 55] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
25 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350-e408. [PMID: 18483207 DOI: 10.1161/circualtionaha.108.189742] [Cited by in Crossref: 784] [Cited by in F6Publishing: 231] [Article Influence: 60.3] [Reference Citation Analysis]
26 Ripplinger CM, Lou Q, Li W, Hadley J, Efimov IR. Panoramic imaging reveals basic mechanisms of induction and termination of ventricular tachycardia in rabbit heart with chronic infarction: implications for low-voltage cardioversion. Heart Rhythm 2009;6:87-97. [PMID: 18996057 DOI: 10.1016/j.hrthm.2008.09.019] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
27 Gopinathannair R, Cornwell WK, Dukes JW, Ellis CR, Hickey KT, Joglar JA, Pagani FD, Roukoz H, Slaughter MS, Patton KK; On behalf of the American Heart Association Electrocardiography and Arrhythmias Committee; Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; and Council on Cardiovascular and Stroke Nursing. Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association. Circulation 2019;139. [DOI: 10.1161/cir.0000000000000673] [Cited by in Crossref: 37] [Cited by in F6Publishing: 7] [Article Influence: 18.5] [Reference Citation Analysis]
28 Sadoul N, Mletzko R, Anselme F, Bowes R, Schöls W, Kouakam C, Casteigneau G, Luise R, Iscolo N, Aliot E. Incidence and Clinical Relevance of Slow Ventricular Tachycardia in Implantable Cardioverter-Defibrillator Recipients: An International Multicenter Prospective Study. Circulation 2005;112:946-53. [DOI: 10.1161/circulationaha.105.533513] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
29 Al-Khatib SM, Friedman P, Ellenbogen KA. Defibrillators: Selecting the Right Device for the Right Patient. Circulation 2016;134:1390-404. [PMID: 27799257 DOI: 10.1161/CIRCULATIONAHA.116.021889] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 4.3] [Reference Citation Analysis]
30 Schwab JO, Bonnemeier H, Kleemann T, Brachmann J, Fischer S, Birkenhauer F, Eberhardt F. Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study. Clin Res Cardiol 2015;104:1021-32. [PMID: 26002818 DOI: 10.1007/s00392-015-0870-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
31 Horlbeck FW, Schwab JO. Programming implantable cardioverter/defibrillators and outcomes. F1000Prime Rep 2015;7:10. [PMID: 25705393 DOI: 10.12703/P7-10] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Tsukahara K, Oginosawa Y, Fujino Y, Honda T, Kikuchi K, Nozoe M, Uchida T, Minamiguchi H, Sonoda K, Ogawa M, Ideguchi T, Kizaki Y, Nakamura T, Oba K, Higa S, Yoshida K, Yagyu K, Miyamoto T, Yamagishi Y, Ohe H, Kohno R, Kataoka M, Otsuji Y, Abe H. RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy. J Arrhythm 2021;37:1052-60. [PMID: 34386132 DOI: 10.1002/joa3.12551] [Reference Citation Analysis]
33 Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133:e38-360. [PMID: 26673558 DOI: 10.1161/cir.0000000000000350] [Cited by in Crossref: 2678] [Cited by in F6Publishing: 1858] [Article Influence: 446.3] [Reference Citation Analysis]
34 Santini M, Lunati M, Defaye P. Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD therapy (ADVANCED-D) Trial results. J Interv Card Electrophysiol. 2010;27:127-135. [PMID: 20087760 DOI: 10.1007/s10840-009-9454-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
35 Stempniewicz P, Cheng A, Connolly A, Wang XY, Calkins H, Tomaselli GF, Berger RD, Tereshchenko LG. Appropriate and inappropriate electrical therapies delivered by an implantable cardioverter-defibrillator: effect on intracardiac electrogram. J Cardiovasc Electrophysiol 2011;22:554-60. [PMID: 21087331 DOI: 10.1111/j.1540-8167.2010.01958.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
36 Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, Lombardo E, Regoli F, Biffi M, Burrone V, Denaro A, Boriani G. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J 2009;30:2758-67. [PMID: 19567380 DOI: 10.1093/eurheartj/ehp247] [Cited by in Crossref: 119] [Cited by in F6Publishing: 72] [Article Influence: 9.9] [Reference Citation Analysis]
37 Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm 2016;32:1-28. [PMID: 26949427 DOI: 10.1016/j.joa.2015.12.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
38 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283-e352. [PMID: 23255456 DOI: 10.1161/cir.0b013e318276ce9b] [Cited by in Crossref: 363] [Cited by in F6Publishing: 119] [Article Influence: 40.3] [Reference Citation Analysis]
39 Revenco D, Morgan JP, Tsao L. The dilemma of implantable cardioverter-defibrillator therapy in the geriatric population. J Geriatr Cardiol 2011;8:195-200. [PMID: 22783305 DOI: 10.3724/SP.J.1263.2011.00195] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
40 Israel CW. Mechanisms of sudden cardiac death. Indian Heart J 2014;66 Suppl 1:S10-7. [PMID: 24568819 DOI: 10.1016/j.ihj.2014.01.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
41 Rav Acha M, Milan D. Who should receive the subcutaneous implanted defibrillator?: Timing is not right to replace the transvenous implantable cardioverter defibrillator. Circ Arrhythm Electrophysiol 2013;6:1246-51; discussion 1251. [PMID: 24347600 DOI: 10.1161/CIRCEP.113.000445] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Janardhan AH, Li W, Fedorov VV, Yeung M, Wallendorf MJ, Schuessler RB, Efimov IR. A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails. J Am Coll Cardiol 2012;60:2393-8. [PMID: 23141483 DOI: 10.1016/j.jacc.2012.08.1001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
43 Kaiser DW, Hsia HH, Dubin AM, Liem LB, Viswanathan MN, Zei PC, Wang PJ, Narayan SM, Turakhia MP. The precise timing of tachycardia entrainment is determined by the postpacing interval, the tachycardia cycle length, and the pacing rate: Theoretical insights and practical applications. Heart Rhythm 2016;13:695-703. [PMID: 26611239 DOI: 10.1016/j.hrthm.2015.11.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
44 Chemello D, Subramanian A, Watkins S, Nair K, Nanthakumar K. Implantable cardioverter defibrillator: charge saver, not syncope saver! Can J Cardiol 2010;26:e341-3. [PMID: 21076727 DOI: 10.1016/s0828-282x(10)70458-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Niehues P, Frommeyer G, Reinke F, Eckardt L. [Subcutaneous implantable cardioverter-defibrillator : Current status and perspectives]. Herzschrittmacherther Elektrophysiol 2018;29:349-54. [PMID: 30306303 DOI: 10.1007/s00399-018-0593-8] [Reference Citation Analysis]
46 Michowitz Y, Lellouche N, Contractor T, Bourke T, Wiener I, Buch E, Boyle N, Bersohn M, Shivkumar K. Defibrillation threshold testing fails to show clinical benefit during long-term follow-up of patients undergoing cardiac resynchronization therapy defibrillator implantation. Europace 2011;13:683-8. [PMID: 21252192 DOI: 10.1093/europace/euq519] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
47 Streitner F, Herrmann T, Kuschyk J, Lang S, Doesch C, Papavassiliu T, Streitner I, Veltmann C, Haghi D, Borggrefe M. Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention. PLoS One 2013;8:e63911. [PMID: 23675514 DOI: 10.1371/journal.pone.0063911] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
48 Passman R, Kadish A. Sudden Death Prevention With Implantable Devices. Circulation 2007;116:561-71. [DOI: 10.1161/circulationaha.106.655704] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
49 Manfredi JA, Al-khatib SM, Shaw LK, Thomas L, Fogel RI, Padanilam B, Rardon D, Vatthyam R, Gemma LW, Golden K, Prystowsky EN. Association Between Left Ventricular Ejection Fraction Post-Cardiac Resynchronization Treatment and Subsequent Implantable Cardioverter Defibrillator Therapy for Sustained Ventricular Tachyarrhythmias. Circ: Arrhythmia and Electrophysiology 2013;6:257-64. [DOI: 10.1161/circep.112.000214] [Cited by in Crossref: 54] [Cited by in F6Publishing: 13] [Article Influence: 6.8] [Reference Citation Analysis]
50 Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013;127:e6-e245. [PMID: 23239837 DOI: 10.1161/CIR.0b013e31828124ad] [Cited by in Crossref: 2824] [Cited by in F6Publishing: 1584] [Article Influence: 313.8] [Reference Citation Analysis]
51 Morgan SW, Plank G, Biktasheva IV, Biktashev VN. Low energy defibrillation in human cardiac tissue: a simulation study. Biophys J 2009;96:1364-73. [PMID: 19217854 DOI: 10.1016/j.bpj.2008.11.031] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
52 Epstein AE, Baessler CA, Curtis AB, Estes NM, Gersh BJ, Grubb B, Mitchell LB. Addendum to “Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/ Scientific Statement From the American Heart Association and the North American Society of Pacing and Electrophysiology” Public Safety Issues in Patients With Implantable Defibrillators A Scientific Statement From the American Heart Association and the Heart Rhythm Society. Circulation 2007;115:1170-6. [DOI: 10.1161/circulationaha.106.180203] [Cited by in Crossref: 52] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
53 Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB, Hood M, Pedersen S, Kääb S, Murgatroyd F, Reeve HL, Carter N, Boersma L; EFFORTLESS Investigators. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. Eur Heart J 2014;35:1657-65. [PMID: 24670710 DOI: 10.1093/eurheartj/ehu112] [Cited by in Crossref: 326] [Cited by in F6Publishing: 184] [Article Influence: 46.6] [Reference Citation Analysis]
54 Grabowski M, Gawałko M, Michalak M, Cacko A, Kowara M, Kołodzińska A, Januszkiewicz Ł, Balsam P, Vitali Serdoz L, Winter J, Opolski G. Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center. Cardiol J 2019;26:360-7. [PMID: 29611175 DOI: 10.5603/CJ.a2018.0024] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Thijssen J, Borleffs CJ, van Rees JB, de Bie MK, van der Velde ET, van Erven L, Bax JJ, Cannegieter SC, Schalij MJ. Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach. Eur Heart J 2011;32:2678-87. [PMID: 21646229 DOI: 10.1093/eurheartj/ehr161] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
56 Rowley CP, Gold MR. Subcutaneous Implantable Cardioverter Defibrillator. Circ: Arrhythmia and Electrophysiology 2012;5:587-93. [DOI: 10.1161/circep.111.964676] [Cited by in Crossref: 43] [Cited by in F6Publishing: 5] [Article Influence: 4.8] [Reference Citation Analysis]
57 Chen J, Johnson G, Hellkamp AS, Anderson J, Mark DB, Lee KL, Bardy GH, Poole JE. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2013;61:2161-8. [PMID: 23541974 DOI: 10.1016/j.jacc.2013.02.046] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
58 AbdelWahab A, Sapp J. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate. Curr Cardiol Rep 2017;19:105. [PMID: 28900864 DOI: 10.1007/s11886-017-0924-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
59 Boriani G, Artale P, Biffi M, Martignani C, Frabetti L, Valzania C, Diemberger I, Ziacchi M, Bertini M, Rapezzi C, Parlapiano M, Branzi A. Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Vessels 2007;22:184-92. [PMID: 17533523 DOI: 10.1007/s00380-006-0963-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
60 Connolly SJ. Use and Misuse of Surrogate Outcomes in Arrhythmia Trials. Circulation 2006;113:764-6. [DOI: 10.1161/circulationaha.105.600668] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
61 Quiñonez Uribe RA, Luther S, Diaz-Maue L, Richter C. Energy-Reduced Arrhythmia Termination Using Global Photostimulation in Optogenetic Murine Hearts. Front Physiol 2018;9:1651. [PMID: 30542292 DOI: 10.3389/fphys.2018.01651] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
62 De Maria E, Giacopelli D, Borghi A, Modonesi L, Cappelli S. Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review. World J Cardiol 2017;9:429-36. [PMID: 28603590 DOI: 10.4330/wjc.v9.i5.429] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
63 Ladwig KH, Ronel J, Baumert J, Kolb C. [Psychological comorbidity and quality of life in patients with an implantable cardioverter/defribrillator (ICD)]. Herzschrittmacherther Elektrophysiol 2010;21:129-36. [PMID: 20552319 DOI: 10.1007/s00399-010-0082-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
64 Huikuri HV, Raatikainen MJ, Moerch-Joergensen R, Hartikainen J, Virtanen V, Boland J, Anttonen O, Hoest N, Boersma LV, Platou ES. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J. 2009;30:689-698. [PMID: 19155249 DOI: 10.1093/eurheartj/ehn537] [Cited by in Crossref: 174] [Cited by in F6Publishing: 117] [Article Influence: 14.5] [Reference Citation Analysis]
65 Friedman PA, Mcclelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilkoff B, Glikson M. Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis: The Detect Supraventricular Tachycardia Study. Circulation 2006;113:2871-9. [DOI: 10.1161/circulationaha.105.594531] [Cited by in Crossref: 194] [Cited by in F6Publishing: 40] [Article Influence: 12.9] [Reference Citation Analysis]
66 Buchan S, Kar R, John M, Post A, Razavi M. Electrical Stimulation for Low-Energy Termination of Cardiac Arrhythmias: a Review. Cardiovasc Drugs Ther 2021. [PMID: 34363570 DOI: 10.1007/s10557-021-07236-5] [Reference Citation Analysis]
67 Dimas V, Ayers C, Daniels J, Joglar JA, Hill JA, Naseem RH. Spironolactone therapy is associated with reduced ventricular tachycardia rate in patients with cardiomyopathy. Pacing Clin Electrophysiol 2011;34:309-14. [PMID: 20946289 DOI: 10.1111/j.1540-8159.2010.02888.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
68 Duncker D, Veltmann C. Optimizing Antitachycardia Pacing: Back to the Roots. Circ Arrhythm Electrophysiol 2017;10:e005696. [PMID: 28887364 DOI: 10.1161/CIRCEP.117.005696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
69 Kutyifa V, Zareba W, Moss AJ. ICD programming to reduce shocks and improve outcomes. Curr Cardiol Rep 2014;16:496. [PMID: 24818705 DOI: 10.1007/s11886-014-0496-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
70 Holden AV, Begg GA, Bounford K, Stegemann B, Tayebjee MH. Phase Entrainment of Induced Ventricular Fibrillation: A Human Feasibility and Proof of Concept Study. J Atr Fibrillation 2019;12:2217. [PMID: 32435345 DOI: 10.4022/jafib.2217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation. 2006;113:776-782. [PMID: 16461817 DOI: 10.1161/circulationaha.105.561571] [Cited by in Crossref: 240] [Cited by in F6Publishing: 57] [Article Influence: 16.0] [Reference Citation Analysis]
72 Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS;  American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139:e56-e528. [PMID: 30700139 DOI: 10.1161/cir.0000000000000659] [Cited by in Crossref: 2988] [Cited by in F6Publishing: 1191] [Article Influence: 1494.0] [Reference Citation Analysis]
73 Smith T, van Dessel PF, Theuns DA, Muskens-Heemskerk A, van Domburg RT, Wilde AA, Jordaens L. Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres. Neth Heart J 2011;19:405-11. [PMID: 21773744 DOI: 10.1007/s12471-011-0176-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
74 Watanabe E, Abe H, Watanabe S. Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers. J Arrhythm 2017;33:594-601. [PMID: 29255507 DOI: 10.1016/j.joa.2017.02.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
75 Wilkoff BL, Stern R, Williamson B, Wathen M, Holloman K, Fieberg A, Brown M. Design of the Primary Prevention Parameters Evaluation (PREPARE) trial of implantable cardioverter defibrillators to reduce patient morbidity [NCT00279279]. Trials 2006;7:18. [PMID: 16725036 DOI: 10.1186/1745-6215-7-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
76 Callum K, Graune C, Bowman E, Molden E, Leslie SJ. Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area. World J Cardiol 2021;13:46-54. [PMID: 33791078 DOI: 10.4330/wjc.v13.i3.46] [Reference Citation Analysis]
77 Madhavan M, Friedman PA. Optimal Programming of Implantable Cardiac-Defibrillators. Circulation 2013;128:659-72. [DOI: 10.1161/circulationaha.112.000542] [Cited by in Crossref: 32] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
78 Muser D, Santangeli P, Liang JJ. Management of ventricular tachycardia storm in patients with structural heart disease. World J Cardiol 2017;9:521-30. [PMID: 28706587 DOI: 10.4330/wjc.v9.i6.521] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
79 Koneru JN, Swerdlow CD, Wood MA, Ellenbogen KA. Minimizing Inappropriate or “Unnecessary” Implantable Cardioverter-Defibrillator Shocks: Appropriate Programming. Circ Arrhythm Electrophysiol 2011;4:778-90. [DOI: 10.1161/circep.110.961243] [Cited by in Crossref: 45] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]